Morning Market Losers

Loading...
Loading...
Geron
GERN
fell 50.69% to $1.43 at 9:52 am. Geron announced that, on the basis of an unplanned interim analysis, it is discontinuing its randomized Phase 2 study of imetelstat in metastatic HER2-negative breast cancer. Nordion
NDZ
shares dipped 39.06% to $6.49. Nordion announced its plans to suspend its quarterly dividend after an arbitration loss. Zalicus
ZLCS
shares lost 26.62% to $1.02. Zalicus announced top line results from its Phase 2b clinical trial of Synavive® in rheumatoid arthritis. Synergy Pharmaceuticals
SGYPU
dropped 25.52% to $11.15. Synergy Pharmaceuticals' 52-week trading range is $9.80-$15.88.
Posted In: NewsMovers & ShakersIntraday UpdateMarketsMorning Market Losers
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...